Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01 in Noninfectious Uveitis
Tarsier Pharma, Ltd., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for the treatment of blinding ocular diseases, today announced the successful outcome of a Type C meeting with the U.S. Food and Drug Administration…
Precision Dropper – The Next Revolution in Eye Health
Precision Dropper revolutionizes eye care with a groundbreaking adapter for eye drop bottles that makes eye drop delivery easier than ever before. Backed by a dedicated team and successful crowdfunding, the company is rapidly transforming eye health across the world….
Dry Eye Disease: The Digital Age Epidemic and the Solution by Dr. Agarwals Eye Hospital
Dry Eye Disease is rapidly becoming an epidemic in the digital age, particularly in India’s leading IT centers like Mumbai, where screen-centric lifestyles are prevalent. The condition, caused by an inability of the eyes to produce enough quality tears, results…
